Procter & Gamble Co (NYSE:PG, XETRA:PRG) is set to report fiscal third-quarter earnings on April 24, with investors watching for signs that steady category demand can offset emerging cost and geopolitical pressures, according to Jefferies analysts.
The consumer staples group is expected to deliver results that modestly clear Wall Street expectations, with Jefferies forecasting about 1.6% organic sales growth and earnings per share of roughly $1.56 for the quarter.
That would put performance slightly ahead of consensus estimates on a rounding basis, supported by improving retail trends and broadly stable consumer demand across key household and personal care categories.
Shares of Procter & Gamble enter the earnings release after a period of mixed but generally resilient operating conditions, the analysts wrote. In its prior quarter, the company reported flat organic sales year over year, as strength in Beauty and Health Care categories helped offset declines in Baby, Feminine and Family Care. Management had previously flagged that the second fiscal quarter would likely be the softest of the year due to inventory normalization and comparisons distorted by earlier shipping disruptions and pantry-loading behavior.
Jefferies noted that underlying retail sell-through trends have shown improvement into the second half of the fiscal year, and that consumer perceptions in core household product categories remain broadly stable. However, the outlook is being shaped by a more uncertain cost and demand environment heading into fiscal 2026 and beyond.
A key focus for the upcoming print will be commentary on margin pressures, particularly the duration and scale of higher input costs. The geopolitical backdrop, including tensions in the Middle East, is cited as a potential risk factor that could affect both demand patterns and incremental supply chain costs.
While near-term performance is expected to meet expectations, analysts are increasingly attentive to signals around fiscal 2027 sales and profitability trajectories.
On guidance, Jefferies expects P&G to largely reiterate its full-year fiscal 2026 outlook. The company previously set a relatively wide range for organic sales and earnings growth, but expectations are that management may lean toward the lower end of that range given macro uncertainty and geopolitical risks. Incremental caution around demand elasticity and cost inflation could also shape tone for the remainder of the fiscal year.
The firm’s prior outlook anticipated a gradual recovery in underlying growth, supported by pricing normalization, innovation-led volume stabilization, and ongoing productivity initiatives. However, Jefferies has revised down its medium-term assumptions, trimming fiscal 2026 and 2027 earnings forecasts by 1% and 4%, respectively, citing a more cautious consumer environment and exposure to elevated input costs beginning in the next fiscal year.
Despite near-term pressures, Jefferies maintained a positive stance on the stock, pointing to P&G’s scale, category diversification, and historically strong execution in navigating cost cycles. The company’s restructuring initiatives and innovation pipeline are seen as structural supports that could help sustain operating leverage over time, even as growth moderates.
Longer term, the investment view remains anchored in expectations of a gradual return to stronger earnings power, though the timing is less certain given macro volatility.
Jefferies highlighted that valuation has compressed relative to historical levels, reflecting softer earnings momentum, but argues that P&G remains relatively well positioned within the staples sector. They have a $175 price target on the company, which traded hands at about $143 on Tuesday afternoon.